420 related articles for article (PubMed ID: 29900542)
1. Free Kappa light chains in neuroinflammatory disorders: Complement rather than substitute?
Bayart JL; Muls N; van Pesch V
Acta Neurol Scand; 2018 Oct; 138(4):352-358. PubMed ID: 29900542
[TBL] [Abstract][Full Text] [Related]
2. CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexes.
Gurtner KM; Shosha E; Bryant SC; Andreguetto BD; Murray DL; Pittock SJ; Willrich MAV
Clin Chem Lab Med; 2018 Jun; 56(7):1071-1080. PubMed ID: 29455184
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid kappa and lambda free light chains in oligoclonal band-negative patients with suspected multiple sclerosis.
Ferraro D; Trovati A; Bedin R; Natali P; Franciotta D; Santangelo M; Camera V; Vitetta F; Varani M; Trenti T; Gastaldi M; De Biasi S; Nasi M; Pinti M; Meletti S; Sola P
Eur J Neurol; 2020 Mar; 27(3):461-467. PubMed ID: 31710409
[TBL] [Abstract][Full Text] [Related]
4. The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis.
Schwenkenbecher P; Konen FF; Wurster U; Jendretzky KF; Gingele S; Sühs KW; Pul R; Witte T; Stangel M; Skripuletz T
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30501024
[TBL] [Abstract][Full Text] [Related]
5. Kappa free light chains in cerebrospinal fluid to identify patients with oligoclonal bands.
Süße M; Hannich M; Petersmann A; Zylla S; Pietzner M; Nauck M; Dressel A
Eur J Neurol; 2018 Sep; 25(9):1134-1139. PubMed ID: 29683546
[TBL] [Abstract][Full Text] [Related]
6. High sensitivity and specificity of elevated cerebrospinal fluid kappa free light chains in suspected multiple sclerosis.
Hassan-Smith G; Durant L; Tsentemeidou A; Assi LK; Faint JM; Kalra S; Douglas MR; Curnow SJ
J Neuroimmunol; 2014 Nov; 276(1-2):175-9. PubMed ID: 25146968
[TBL] [Abstract][Full Text] [Related]
7. Association of cerebrospinal fluid kappa free light chains with the intrathecal polyspecific antiviral immune response in multiple sclerosis.
Huss A; Mojib-Yezdani F; Bachhuber F; Fangerau T; Lewerenz J; Otto M; Tumani H; Senel M
Clin Chim Acta; 2019 Nov; 498():148-153. PubMed ID: 31437445
[TBL] [Abstract][Full Text] [Related]
8. CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort.
Senel M; Mojib-Yezdani F; Braisch U; Bachhuber F; Lewerenz J; Ludolph AC; Otto M; Tumani H
Front Immunol; 2019; 10():641. PubMed ID: 30984199
[No Abstract] [Full Text] [Related]
9. Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis.
Presslauer S; Milosavljevic D; Brücke T; Bayer P; Hübl W
J Neurol; 2008 Oct; 255(10):1508-14. PubMed ID: 18685917
[TBL] [Abstract][Full Text] [Related]
10. Free light chain monomer-dimer patterns in the diagnosis of multiple sclerosis.
Kaplan B; Golderman S; Yahalom G; Yeskaraev R; Ziv T; Aizenbud BM; Sela BA; Livneh A
J Immunol Methods; 2013 Apr; 390(1-2):74-80. PubMed ID: 23376556
[TBL] [Abstract][Full Text] [Related]
11. Application of κ free light chains in cerebrospinal fluid as a biomarker in multiple sclerosis diagnosis: development of a diagnosis algorithm.
Valencia-Vera E; Martinez-Escribano Garcia-Ripoll A; Enguix A; Abalos-Garcia C; Segovia-Cuevas MJ
Clin Chem Lab Med; 2018 Mar; 56(4):609-613. PubMed ID: 29087953
[TBL] [Abstract][Full Text] [Related]
12. Kappa free light chains in cerebrospinal fluid as markers of intrathecal immunoglobulin synthesis.
Fischer C; Arneth B; Koehler J; Lotz J; Lackner KJ
Clin Chem; 2004 Oct; 50(10):1809-13. PubMed ID: 15271859
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid free kappa light chains and kappa index perform equal to oligoclonal bands in the diagnosis of multiple sclerosis.
Christiansen M; Gjelstrup MC; Stilund M; Christensen T; Petersen T; Jon Møller H
Clin Chem Lab Med; 2018 Dec; 57(2):210-220. PubMed ID: 30055097
[TBL] [Abstract][Full Text] [Related]
14. Quantification of immunoglobulin free light chains in cerebrospinal fluid by nephelometry.
Desplat-Jégo S; Feuillet L; Pelletier J; Bernard D; Chérif AA; Boucraut J
J Clin Immunol; 2005 Jul; 25(4):338-45. PubMed ID: 16133990
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis-from diagnosis to prediction of disease activity.
Hegen H; Berek K; Deisenhammer F
Wien Med Wochenschr; 2022 Nov; 172(15-16):337-345. PubMed ID: 35133530
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis.
Makshakov G; Nazarov V; Kochetova O; Surkova E; Lapin S; Evdoshenko E
PLoS One; 2015; 10(11):e0143375. PubMed ID: 26606531
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis.
Gaetani L; Di Carlo M; Brachelente G; Valletta F; Eusebi P; Mancini A; Gentili L; Borrelli A; Calabresi P; Sarchielli P; Ferri C; Villa A; Di Filippo M
J Neuroimmunol; 2020 Feb; 339():577108. PubMed ID: 31743879
[TBL] [Abstract][Full Text] [Related]
18. [Clinical usefulness of oligoclonal bands].
Falip M; Tintoré M; Jardí R; Duran I; Link H; Montalbán X
Rev Neurol; 2001 Jun 16-30; 32(12):1120-4. PubMed ID: 11562840
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis.
Hegen H; Walde J; Berek K; Arrambide G; Gnanapavan S; Kaplan B; Khalil M; Saadeh R; Teunissen C; Tumani H; Villar LM; Willrich MAV; Zetterberg H; Deisenhammer F
Mult Scler; 2023 Feb; 29(2):169-181. PubMed ID: 36453167
[TBL] [Abstract][Full Text] [Related]
20. Clinical Use of κ Free Light Chains Index as a Screening Test for Multiple Sclerosis.
Agnello L; Lo Sasso B; Salemi G; Altavilla P; Pappalardo EM; Caldarella R; Meli F; Scazzone C; Bivona G; Ciaccio M
Lab Med; 2020 Jul; 51(4):402-407. PubMed ID: 31943078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
